Brookline Capital Markets Starts Progenics Pharmaceuticals (PGNX) at Buy
Brookline Capital Markets analyst Kumaraguru Raja initiates coverage on Progenics Pharmaceuticals ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)